SAREPTA THERAPEUTICS, INC. Repayments of Debt
SAREPTA THERAPEUTICS, INC. (SRPT) reported Repayments of Debt of $1.26 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2021-03-01
- SAREPTA THERAPEUTICS, INC. repayments of debt for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. repayments of debt for the quarter ending 2018-09-30 was $0.00.
- SAREPTA THERAPEUTICS, INC. repayments of debt for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. repayments of debt for the quarter ending 2018-03-31 was $1.26M, a 2841.86% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. repayments of debt for fiscal 2018 was $1.26M, a 1060.55% increase from fiscal 2017.
- SAREPTA THERAPEUTICS, INC. repayments of debt for fiscal 2017 was $109.00K, a 95.81% decline from fiscal 2016.
- SAREPTA THERAPEUTICS, INC. repayments of debt for fiscal 2016 was $2.60M, a 0.19% increase from fiscal 2015.
- SAREPTA THERAPEUTICS, INC. repayments of debt for fiscal 2015 was $2.60M, a 2663.83% increase from fiscal 2014.
| Period end | Repayments of Debt 3 month | Repayments of Debt 3 month as first filed | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 9 month as first filed | Repayments of Debt 12 month | Repayments of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $1.26M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $1.26M 10-Q · filed 2019-11-07 | $1.29M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.26M 10-Q · filed 2019-08-07 | $1.29M derived: sum of 3 quarters · filed 2020-02-26 | -$3.68M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | $1.26M 10-Q · filed 2019-05-08 | $1.29M derived: sum of 2 quarters · filed 2020-02-26 | -$3.68M derived: sum of 3 quarters · filed 2020-02-26 | $1.33M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$4.95M derived: sum of 2 quarters · filed 2020-02-26 | $66.00K derived: sum of 3 quarters · filed 2020-02-26 | $109.00K 10-K · filed 2020-02-26 | $15.11M 10-K · filed 2018-03-01 | ||
| 2017-09-30 | -$4.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $38.00K derived: sum of 2 quarters · filed 2018-10-31 | $81.00K 10-Q · filed 2018-10-31 | $15.08M 10-Q · filed 2017-11-01 | -$2.39M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $5.05M 10-Q · filed 2017-08-03 | $2.58M derived: sum of 3 quarters · filed 2019-02-28 | $5.11M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $43.00K 10-Q · filed 2018-05-03 | $2.54M 10-Q · filed 2017-05-04 | -$2.43M derived: sum of 2 quarters · filed 2019-02-28 | $95.00K derived: sum of 3 quarters · filed 2019-02-28 | $121.00K derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2016-12-31 | -$2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $52.00K derived: sum of 2 quarters · filed 2019-02-28 | $78.00K derived: sum of 3 quarters · filed 2019-02-28 | $2.60M 10-K · filed 2019-02-28 | $7.60M 10-K · filed 2017-02-28 | ||
| 2016-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $2.55M derived: sum of 2 quarters · filed 2017-11-01 | $5.08M 10-Q · filed 2017-11-01 | $5.10M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.55M 10-Q · filed 2017-08-03 | $2.58M derived: sum of 3 quarters · filed 2018-03-01 | $5.10M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $2.52M 10-Q · filed 2017-05-04 | $2.55M derived: sum of 2 quarters · filed 2018-03-01 | $5.07M derived: sum of 3 quarters · filed 2018-03-01 | $5.10M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.55M derived: sum of 2 quarters · filed 2018-03-01 | $2.57M derived: sum of 3 quarters · filed 2018-03-01 | $2.60M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.55M derived: sum of 2 quarters · filed 2016-11-07 | $2.57M 10-Q · filed 2016-11-07 | $2.60M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $49.00K 10-Q · filed 2016-08-09 | $73.00K derived: sum of 3 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $25.00K 10-Q · filed 2016-05-05 | $49.00K derived: sum of 2 quarters · filed 2017-02-28 | |||||
| 2014-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $94.00K 10-K · filed 2017-02-28 | |||||
| 2014-09-30 | $70.00K 10-Q · filed 2015-11-05 | ||||||
| 2013-12-31 | $89.00K 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |